Iressa 250 mg – 30 Tablets

Iressa 250 mg is an anti-cancer medication used to treat advanced or metastatic non-small cell lung cancer (NSCLC), particularly in patients with specific epidermal growth factor receptor (EGFR) mutations. It contains the active ingredient gefitinib, which inhibits tyrosine kinase receptors, blocking the growth and spread of cancer cells.

Indications:

• Treatment of NSCLC with confirmed EGFR mutations

How to Use:

• Take orally, one 250 mg tablet once daily, with or without food

• Take the medication at the same time each day

Warnings & Precautions:

• EGFR mutation testing should be confirmed before starting treatment

• May cause diarrhea, skin rash, or dry skin

• Use with caution in patients with liver or kidney problems

• Avoid pregnancy during treatment and for a period after stopping; use effective contraception

Storage:

• Store at room temperature

• Keep away from moisture and direct light

• Keep out of reach of children